These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 6886520)

  • 1. Isotopic bone mineralization rates in maintenance dialysis patients.
    Cochran M; Stephens E
    J Lab Clin Med; 1983 Sep; 102(3):324-31. PubMed ID: 6886520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bone formation rates measured by radiocalcium kinetics and double-tetracycline labeling in maintenance dialysis patients.
    Cochran M; Cochran M; Neville A; Marshall EA
    Calcif Tissue Int; 1994 May; 54(5):392-8. PubMed ID: 8062157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
    Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study.
    Lezaic V; Pejanovic S; Kostic S; Pljesa S; Dimkovic N; Komadina L; Jovanovic D; Marinkovic J; Djukanovic L
    Ther Apher Dial; 2007 Apr; 11(2):121-30. PubMed ID: 17381533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tumor-induced osteomalacia on the bone mineralization process.
    Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
    Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease.
    Grzegorzewska AE; Młot M
    Rocz Akad Med Bialymst; 2004; 49():190-2. PubMed ID: 15631341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.
    Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S
    Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism.
    Esposito MG; Cesare CM; De Santo RM; Cice G; Perna AF; Violetti E; Conzo G; Bilancio G; Celsi S; Annunziata F; Iannelli S; De Santo NG; Cirillo M; Livrea A
    J Nephrol; 2008; 21 Suppl 13():S92-6. PubMed ID: 18446739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
    Chow TL; Chan TT; Ho YW; Lam SH
    Arch Surg; 2007 Jul; 142(7):644-8. PubMed ID: 17638802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum osteoprotegerin level is lower in peritoneal dialysis patients than in hemodialysis ones.
    Grzegorzewska AE; Młot M
    Rocz Akad Med Bialymst; 2004; 49():193-6. PubMed ID: 15631342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma bone Gla-protein: assessment of its clinical value as an index of bone formation in hemodialyzed patients.
    Sebert JL; Ruiz JC; Fournier A; Fardellone P; Guéris J; Marié A; Morinière P; Codet MP; Renaud H
    Bone Miner; 1987 Feb; 2(1):21-7. PubMed ID: 3509784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panostotic fibrous dysplasia: a congenital disorder of bone with unusual facial appearance, bone fragility, hyperphosphatasemia, and hypophosphatemia.
    Cole DE; Fraser FC; Glorieux FH; Jequier S; Marie PJ; Reade TM; Scriver CR
    Am J Med Genet; 1983 Apr; 14(4):725-35. PubMed ID: 6846403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of inactivity on bone mineralization].
    Kocián J
    Cas Lek Cesk; 1992 May; 131(10):297-300. PubMed ID: 1638593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of plasma calcium, phosphate, and alkaline phosphatase measurements in the diagnosis of histological osteomalacia.
    Peach H; Compston JE; Vedi S; Horton LW
    J Clin Pathol; 1982 Jun; 35(6):625-30. PubMed ID: 7085914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary hyperparathyroidism in osteomalacia.
    Thalassinos NC; Wicht S; Joplin GF
    Br Med J; 1970 Jan; 1(5688):76-9. PubMed ID: 5411449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoid mineralization defect in primary hyperparathyroidism.
    Bordier PJ; Woodhouse NJ; Sigurdsson G; Joplin GF
    Clin Endocrinol (Oxf); 1973 Oct; 2(4):377-86. PubMed ID: 4766953
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of chronic uremia on bone.
    Denneberg T; Johnell O; Nilsson BE; Wiklund PE
    Scand J Urol Nephrol; 1982; 16(3):275-8. PubMed ID: 7163791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.